Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 octubre 2013

RADIOLOGY. Investigational Vertebroplasty Safety and Efficacy Trial (INVEST): Patient-reported Outcomes through 1 Year

Bryan A. Comstock, MS, , Colleen M. Sitlani, PhD, , Jeffrey G. Jarvik, MD, MPH, , Patrick J. Heagerty, PhD, , Judith A. Turner, PhD, and , David F. Kallmes, MD

Spontaneous, painful vertebral fractures represent an important cause of morbidity and mortality among patients with osteoporosis. Percutaneous vertebroplasty—the injection of medical cement, or polymethylmethacrylate (PMMA) (Parallax Medical, Wilmington, Mass), into the fractured vertebral body—has gained widespread acceptance as a method of pain relief and is a part of routine therapy for osteoporotic vertebral fractures (1).

01 octubre 2014

RADIOLOGY. Reperfusion Is a Stronger Predictor of Good Clinical Outcome than Recanalization in Ischemic Stroke

Gyojun Hwang, MD, PhD, Jeong Gyun Kim, MD, Kyung Sun Song, MD, Young Jin Lee, MD, Jay Bautista Villavicencio, MD, Nur Setiawan Suroto, MD, Nam-Mi Park, RN, Soo Joo Park, RN, Eun-A Jeong, RN, O-Ki Kwon, MD, PhD

To evaluate characteristics of delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysms and to determine the optimal duration of dual antiplatelet therapy for its prevention.

01 octubre 2014

RADIOLOGY. Natural History of Asymptomatic Unruptured Cerebral Aneurysms Evaluated at CT Angiography: Growth and Rupture Incidence and Correlation with Epidemiologic Risk Factors

Gyojun Hwang, MD, PhD, Jeong Gyun Kim, MD, Kyung Sun Song, MD, Young Jin Lee, MD, Jay Bautista Villavicencio, MD, Nur Setiawan Suroto, MD, Nam-Mi Park, RN, Soo Joo Park, RN, Eun-A Jeong, RN, O-Ki Kwon, MD, PhD

To evaluate characteristics of delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysms and to determine the optimal duration of dual antiplatelet therapy for its prevention.

01 agosto 2013

RADIOLOGY. Neuronal Excitotoxicity after Carotid Angioplasty and Stent Placement Procedures

Florentino Nombela, MD, PhD, , Miguel Blanco, MD, PhD, , Natalia Pérez de la Ossa, MD, PhD, , José Luis Caniego, MD, PhD, , Tomás Sobrino, PhD, , Domingo Escudero, MD, PhD, , Francisco Campos, PhD1, , María Ángeles Moro, PhD, , Ignacio Lizasoaín, MD, PhD, , Antoni Dávalos, MD, PhD, , José Castillo, MD, PhD, and , José Vivancos, MD, PhD

Glutamate-mediated excitotoxicity is one of the pathophysiological mechanisms of spreading brain injury in acute ischemic stroke (1,2). The overactivation of glutamate ionotropic receptors (mainly n-methyl-d-aspartate–NMDA) and metabotropic receptors leads to high intracellular calcium concentrations and initiates the process known as ischemic cascade. Increased levels of extracellular glutamate in acute cerebral ischemia are the result of presynaptic release and the failure of glutamate homeostatic transport system. Excitatory amino acid transporters, which usually uptake extracellular glutamate into neurons, glia, and endothelial cells, can contribute to the release of glutamate from intracellular spaces under ischemic conditions (3–5).

01 agosto 2013

AMERICAN JOURNAL OF ROENTGENOLOGY. Effects of Low-Dose Protocols in Endovascular Treatment of Intracranial Aneurysms: Development of Workflow Task Analysis During Cerebral Endovascular Procedures

Jean Christophe Gentric, Pierre Jannin, Brivael Trelhu, Laurent Riffaud , Hélène Raoult, Jean Christophe Ferré and Jean Yves Gauvrit

OBJECTIVE. Reducing radiation exposure through the use of low-dose protocols during cerebral endovascular procedures is recommended, but evaluation of the impact on the procedure itself is difficult and subjective. A workflow task analysis could provide an objective comparison of two different radiation exposure protocols.

07 mayo 2013

STROKE. Clinical Sciences Impact of Acute Cocaine Use on Aneurysmal Subarachnoid Hemorrhage

Tiffany R. Chang, MD; Robert G. Kowalski, MBBCh, MS; Filissa Caserta, MSN, ACNP-BC, CNRN; Juan Ricardo Carhuapoma, MD; Rafael J. Tamargo, MD; Neeraj S. Naval, MD

Background and Purpose: Acute cocaine use has been temporally associated with aneurysmal subarachnoid hemorrhage (aSAH). This study analyzes the impact of cocaine use on patient presentation, complications, and outcomes.

02 mayo 2013

STROKE. Clinical Sciences. White-Coat and Masked Hypertension Are Associated With Carotid Atherosclerosis in a General Population

Masayo Fukuhara, MD, PhD; Hisatomi Arima, MD, PhD; Toshiharu Ninomiya, MD, PhD; Jun Hata, MD, PhD; Yoichiro Hirakawa, MD, PhD; Yasufumi Doi, MD, PhD; Koji Yonemoto, PhD; Naoko Mukai, MD, PhD; Masaharu Nagata, MD, PhD; Fumie Ikeda, MD, PhD; Kiyoshi Matsumura, MD, PhD; Takanari Kitazono, MD, PhD; Yutaka Kiyohara, MD, PhD

Background and Purpose: On the basis of combined measurements of clinic blood pressure (CBP) and home blood pressure (HBP), blood pressure status can be divided into normotension, white-coat hypertension (WCHT), masked hypertension (MHT), and sustained hypertension (SHT). Despite the clear impact of MHT and SHT on clinical and subclinical arterial disease, uncertainty about the influence of WCHT remains. The objective of this study was to investigate the associations of WCHT, MHT, and SHT with carotid atherosclerosis in a general population.

30 abril 2013

STROKE. Clinical Sciences. Comparison of Risk-scoring Systems in Predicting Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis

Sheng-Feng Sung, MD; Solomon Chih-Cheng Chen, MD, PhD; Huey-Juan Lin, MD, MPH; Yu-Wei Chen, MD; Mei-Chiun Tseng, PhD; Chih-Hung Chen, MD

Background and Purpose: Various risk score models have been developed to predict symptomatic intracerebral hemorrhage (SICH) after intravenous thrombolysis for acute ischemic stroke. In this study, we aimed to determine the prediction performance of these risk scores in a Taiwanese population

16 mayo 2013

STROKE. Clinical Sciences. New Generation of Flow Diverter (Surpass) for Unruptured Intracranial Aneurysms. A Prospective Single-Center Study in 37 Patients

Joost De Vries, MD, PhD; Jeroen Boogaarts, MD; Anouk Van Norden, MD, PhD; Ajay K. Wakhloo, MD, PhD

Background and Purpose: In patients harboring intracranial aneurysms, the major goal in treatment is to prevent bleeding. A new generation of an endoluminal device (Surpass Flow Diverter [Surpass]) was developed to reconstruct parent artery and occlude the aneurysm. We present our clinical and angiographic single-center experience.

30 abril 2013

STROKE. Clinical Sciences. External Validation of the SEDAN Score for Prediction of Intracerebral Hemorrhage in Stroke Thrombolysis

Michael V. Mazya, MD; Paolo Bovi, MD, PhD; José Castillo, MD, PhD; Dalius Jatuzis, MD, PhD; Adam Kobayashi, MD, PhD; Nils Wahlgren, MD, PhD; Niaz Ahmed, MD, PhD

Background and Purpose: The SEDAN score is a prediction rule for assessment of the risk of symptomatic intracerebral hemorrhage (SICH) per the European Cooperative Acute Stroke Study (ECASS) II definition in patients with acute ischemic stroke treated with intravenous thrombolysis. We assessed the performance of the score in predicting SICH per the ECASS II and Safe Implementation of Treatments in Stroke Monitoring Study (SITS-MOST) definitions in the SITS–International Stroke Thrombolysis Register (SITS-ISTR).

01 julio 2014

AMERICAN HEART JOURNAL. Preprocedural statin use in patients undergoing percutaneous coronary intervention

Mohamad Kenaan, MD, Milan Seth, MS, Herbert D. Aronow, MD, Joseph Naoum, MD, Douglas Wunderly, MD, James Mitchiner, MD, Mauro Moscucci, MD, Hitinder S. Gurm, MD, Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Background: Earlier studies suggest that administering statins prior to percutaneous coronary interventions (PCIs) is associated with lower risk of periprocedural myocardial infarction and contrast-induced nephropathy. Current American College of Cardiology/American Heart Association guidelines recommend routine use of statins prior to PCI. It is unclear how commonly this recommendation is followed in clinical practice and what its effect on outcomes is.

15 junio 2014

THE AMERICAN JOURNAL OF CARDIOLOGY. Effect of Sustaining Lifestyle Modifications (Nonsmoking, Weight Reduction, Physical Activity, and Mediterranean Diet) After Healing of Myocardial Infarction, Percutaneous Intervention, or Coronary Bypass (from the REasons for Geographic and Racial Differences in Stroke Study)

John N. Booth III, MS, Emily B. Levitan, DSc, Todd M. Brown, MD, MSPH, Michael E. Farkouh, MD, Monika M. Safford, MD, Paul Muntner, PhD

Guidelines recommend lifestyle modification for patients with coronary heart disease (CHD). Few data demonstrate which lifestyle modifications, if sustained, reduce recurrent CHD and mortality risk in cardiac patients after the postacute rehabilitation phase. We determined the association between ideal lifestyle factors and recurrent CHD and all-cause mortality in REasons for Geographic and Racial Differences in Stroke study participants with CHD (n = 4,174). Ideal lifestyle factors (physical activity ≥4 times/week, nonsmoking, highest quartile of Mediterranean diet score, and waist circumference <88 cm for women and <102 cm for men) were assessed through questionnaires and an in-home study visit. There were 447 recurrent CHD events and 745 deaths over a median 4.3 and 4.5 years, respectively. After multivariable adjustment, physical activity ≥4 versus no times/week and non-smoking versus current smoking were associated with reduced hazard ratios (HRs; 95% confidence interval [CI]) for recurrent CHD (HR 0.69, 95% CI 0.54 to 0.89 and HR 0.50, 95% CI 0.39 to 0.64, respectively) and death (HR 0.71, 95% CI 0.59 to 0.86 and HR 0.53, 95% CI 0.44 to 0.65, respectively). The multivariable-adjusted HRs (and 95% CIs) for recurrent CHD and death comparing the highest versus lowest quartile of Mediterranean diet adherence were 0.77 (95% CI 0.55 to 1.06) and 0.84 (95% CI 0.67 to 1.07), respectively. Neither outcome was associated with waist circumference. Comparing participants with 1, 2, and 3 versus 0 ideal lifestyle factors (non-smoking, physical activity ≥4 times/week, and highest quartile of Mediterranean diet score), the HRs (and 95% CIs) were 0.60 (95% CI 0.44 to 0.81), 0.49 (95% CI 0.36 to 0.67), and 0.38 (95% CI 0.21 to 0.67), respectively, for recurrent CHD and 0.65 (95% CI 0.51 to 0.83), 0.57 (95% CI 0.43 to 0.74), and 0.41 (95% CI 0.26 to 0.64), respectively, for death. In conclusion, maintaining smoking cessation, physical activity, and Mediterranean diet adherence is important for secondary CHD prevention.

18 abril 2013

STROKE. Clinical Sciences. Coronary Artery Disease and Risk of Major Vascular Events After Cerebral Infarction

Pierre Amarenco, MD; Philippa C. Lavallée, MD; Julien Labreuche, BS; Gregory Ducrocq, MD; Jean-Michel Juliard, MD, PhD; Laurent Feldman, MD, PhD; Lucie Cabrejo, MD; Elena Meseguer, MD; Céline Guidoux, MD; Valérie Adraï, MD; Samina Ratani, MD; Jérôme Kusmierek, MD; Bertrand Lapergue, MD, PhD; Isabelle F. Klein, MD, PhD; Fernando Gongora-Rivera, MD; Arturo Jaramillo, MD; Halim Abboud, MD; Jean-Marc Olivot, MD, PhD; Mikael Mazighi, MD, PhD; Pierre-Jean Touboul, MD; Philippe Gabriel Steg, MD

Background and Purpose: The impact of asymptomatic coronary artery disease on the risk of major vascular events in patients with cerebral infarction is unknown.

05 abril 2013

STROKE. Interventional Treatment of Acute Ischemic Stroke. Devices and Clinical Trials

Joseph P. Broderick, MD

In an ideal world, our decision to enroll patients in clinical trials would be based on thoughtful, rational, informed, and balanced considerations of available and relevant scientific and clinical data. In reality, our decision making is based more often on our recent clinical experience and the opinions of those clinicians we value. To increase the appropriate and thoughtful enrollment of patients into clinical trials, it is helpful to examine how we make these decisions and the limitations of equipoise as a decision-making tool.

09 abril 2013

STROKE. Interventional Treatment of Acute Ischemic Stroke. The Evolution of Technology

Jeffrey L. Saver, MD

The historical development of technologies for catheter-based reperfusion of the acutely ischemic human brain is brief but eventful (Table). The first clinical patients were treated with local microcatheter delivery of intra-arterial fibrinolytics in the mid-1990s. The first mechanical recanalization technique, primary intra-arterial balloon angioplasty, was described a few years later. Over the subsequent decade and a half, successive waves of innovative mechanical thrombectomy devices were introduced. The rapid proliferation of technology reflects the inherent dynamic of biomechanical device development, characterized by rapid engineering innovation focused on a well-circumscribed target, in contrast to the slower, more deliberate arc of drug development, which requires extensive testing of each new molecular entity for unexpected off-target effects on diverse organs.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.